Please use this identifier to cite or link to this item: https://doi.org/10.21256/zhaw-3822
Publication type: Article in scientific journal
Type of review: Peer review (publication)
Title: A novel microplate 3D bioprinting platform for the engineering of muscle and tendon tissues
Authors: Laternser, Sandra
Keller, Hansjoerg
Leupin, Olivier
Rausch, Martin
Graf-Hausner, Ursula
Rimann, Markus
DOI: 10.21256/zhaw-3822
10.1177/2472630318776594
Published in: SLAS Technology: Translating Life Sciences Innovation
Volume(Issue): 23
Issue: 6
Pages: 599
Pages to: 613
Issue Date: 12-Jun-2018
Publisher / Ed. Institution: Sage
ISSN: 2472-6303
2472-6311
Language: English
Subjects: 3D bioprinting; 3D cell culture; Bioink; Drug development; Muscle tissue engineering
Subject (DDC): 610: Medicine and health
Abstract: Two-dimensional (2D) cell cultures do not reflect the in vivo situation, and thus it is important to develop predictive three-dimensional (3D) in vitro models with enhanced reliability and robustness for drug screening applications. Treatments against muscle-related diseases are becoming more prominent due to the growth of the aging population worldwide. In this study, we describe a novel drug screening platform with automated production of 3D musculoskeletal-tendon-like tissues. With 3D bioprinting, alternating layers of photo-polymerized gelatin-methacryloyl-based bioink and cell suspension tissue models were produced in a dumbbell shape onto novel postholder cell culture inserts in 24-well plates. Monocultures of human primary skeletal muscle cells and rat tenocytes were printed around and between the posts. The cells showed high viability in culture and good tissue differentiation, based on marker gene and protein expressions. Different printing patterns of bioink and cells were explored and calcium signaling with Fluo4-loaded cells while electrically stimulated was shown. Finally, controlled co-printing of tenocytes and myoblasts around and between the posts, respectively, was demonstrated followed by co-culture and co-differentiation. This screening platform combining 3D bioprinting with a novel microplate represents a promising tool to address musculoskeletal diseases.
URI: https://digitalcollection.zhaw.ch/handle/11475/7548
Fulltext version: Published version
License (according to publishing contract): CC BY-NC 4.0: Attribution - Non commercial 4.0 International
Departement: Life Sciences and Facility Management
Organisational Unit: Institute of Chemistry and Biotechnology (ICBT)
Appears in collections:Publikationen Life Sciences und Facility Management

Files in This Item:
File Description SizeFormat 
Laternser2018 muscle bioprinting.pdf974.23 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.